Colorectal cancer risk (16 studies) · Participants in non experimental cohort studies on selenium and cancer
It is very uncertain whether highest changes colorectal cancer risk No. of participants: 712,746 (6 observational… compared with lowest selenium exposure (very low certainty).
1 finding from 1 review
Lung cancer risk (17 studies) · Participants in non experimental cohort studies on selenium and cancer
It is very uncertain whether highest changes lung cancer risk No. of participants: 371,067 (11 observational… compared with lowest selenium exposure (very low certainty).
1 finding from 1 review
Breast cancer risk (14 studies) · Participants in non experimental cohort studies on selenium and cancer
It is very uncertain whether highest changes breast cancer risk (women) No. of participants: 169,028 (8… compared with lowest selenium exposure (very low certainty).
1 finding from 1 review
Bladder cancer risk No. of participants: 279,100 (5 observational studies) · Participants in non experimental cohort studies on selenium and cancer
It is very uncertain whether highest changes bladder cancer risk No. of participants: 279,100 (5 observational… compared with lowest selenium exposure (very low certainty).
1 finding from 1 review
Prostate cancer risk (13 studies) · Participants in non experimental cohort studies on selenium and cancer
It is very uncertain whether highest changes prostate cancer risk No. of participants: 576,667 (21 observational… compared with lowest selenium exposure (very low certainty).
1 finding from 1 review
Cancer mortality risk No. of participants: 17,448 (1 RCT) · Participants in trials with low risk of bias
Highest showed no clear difference in cancer mortality risk No. of participants: 17,448 (1 RCT) compared with lowest selenium exposure (high certainty).
1 finding from 1 review
Colorectal cancer risk (16 studies) · Participants in trials with low risk of bias
Highest showed no clear difference in colorectal cancer risk No. of participants: 19,009 (2 RCTs) compared with lowest selenium exposure (high certainty).
1 finding from 1 review
Non‐melanoma skin cancer risk No. of participants: 2027 (2 RCTs) · Participants in trials with low risk of bias
Highest showed no clear difference in non‐melanoma skin cancer risk No. of participants: 2027 (2 RCTs) compared with lowest selenium exposure (moderate certainty).
1 finding from 1 review
Lung cancer risk (17 studies) · Participants in trials with low risk of bias
Highest showed no clear difference in lung cancer risk No. of participants: 19,009 (2 RCTs) compared with lowest selenium exposure (high certainty).
1 finding from 1 review
Breast cancer risk (14 studies) · Participants in trials with low risk of bias
Highest showed no clear difference in breast cancer risk No. of participants: 802 (1 RCT) compared with lowest selenium exposure (moderate certainty).
1 finding from 1 review
Bladder cancer risk No. of participants: 19,009 (2 RCTs) · Participants in trials with low risk of bias
Highest showed no clear difference in bladder cancer risk No. of participants: 19,009 (2 RCTs) compared with lowest selenium exposure (high certainty).
1 finding from 1 review
Prostate cancer risk (13 studies) · Participants in trials with low risk of bias
Highest showed no clear difference in prostate cancer risk No. of participants: 18,942 (4 RCTs) compared with lowest selenium exposure (high certainty).
1 finding from 1 review
Any cancer risk No. of participants: 76,239 (7 observational studies) · Participants in non experimental cohort studies on selenium and cancer
It is very uncertain whether highest changes any cancer risk No. of participants: 76,239 (7 observational studies) compared with lowest selenium exposure (very low certainty).
1 finding from 1 review
Decision self‐confidence: Decision self‐efficacy scale (O'Connor 1995): range 0 to 100 (none to perfect self‐efficacy) measured 12 weeks post‐intervention (McBride 2016)
1 finding from 1 review
Preparation for decision‐making
1 finding from 1 review
Aerobic capacity · people with dermatomyositis and polymyositis
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Patient satisfaction The degree of satisfaction · general patient population, "at risk" patient population and patient population with a specific condition or disease
1 finding from 1 review
Activity level: Tegner score ( 0 to 10; higher scores = greater activity) · adults undergoing arthroscopically assisted ACL reconstruction1
1 finding from 1 review
Intervention not reported
Pain score for highest level before leaving clinic (100 mm VAS) · women with IUC being inserted
The intervention probably leads to higher pain score for highest level before leaving clinic (100 mm VAS) (moderate certainty).
1 finding from 1 review
MD 7.6 [6.48, 8.72]
105 participants
Moderate
Activity level: Tegner score ( 0 to 10; higher scores = greater activity) · People, primarily adults, undergoing ACL reconstruction surgery
1 finding from 1 review